Dynavax Technologies (DVAX) EBIAT (2016 - 2025)
Historic EBIAT for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $26.9 million.
- Dynavax Technologies' EBIAT rose 5304.65% to $26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.4 million, marking a year-over-year decrease of 31193.96%. This contributed to the annual value of $27.3 million for FY2024, which is 52743.78% up from last year.
- Dynavax Technologies' EBIAT amounted to $26.9 million in Q3 2025, which was up 5304.65% from $18.7 million recorded in Q2 2025.
- Dynavax Technologies' 5-year EBIAT high stood at $128.8 million for Q2 2022, and its period low was -$96.1 million during Q1 2025.
- For the 5-year period, Dynavax Technologies' EBIAT averaged around $17.9 million, with its median value being $11.4 million (2024).
- Its EBIAT has fluctuated over the past 5 years, first soared by 358787.88% in 2022, then plummeted by 100192.64% in 2025.
- Dynavax Technologies' EBIAT (Quarter) stood at $99.8 million in 2021, then plummeted by 32.12% to $67.7 million in 2022, then plummeted by 99.68% to $219000.0 in 2023, then surged by 3119.18% to $7.0 million in 2024, then surged by 281.94% to $26.9 million in 2025.
- Its EBIAT was $26.9 million in Q3 2025, compared to $18.7 million in Q2 2025 and -$96.1 million in Q1 2025.